Mbd Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-06-2024
- Paid Up Capital ₹ 0.10 M
as on 17-06-2024
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.00 M
as on 17-06-2024
- Revenue -17.34%
(FY 2022)
- Profit 50.01%
(FY 2022)
- Ebitda 77.51%
(FY 2022)
- Net Worth -57.39%
(FY 2022)
- Total Assets -74.14%
(FY 2022)
About Mbd Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.00 M.
Harsh Sharma and Anil Goswami serve as directors at the Company.
- CIN/LLPIN
U24233UP2013PTC056729
- Company No.
056729
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 May 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Sahibabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Mbd Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harsh Sharma  | Director | 10-Feb-2020 | Current |
| Anil Goswami | Director | 21-Jul-2021 | Current |
Financial Performance and Corporate Structure Insights of Mbd Pharma.
Mbd Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 17.34% decrease. The company also saw a substantial improvement in profitability, with a 50.01% increase in profit. The company's net worth observed a substantial decline by a decrease of 57.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mbd Pharma?
In 2021, Mbd Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Aarambh Enterprises Private LimitedActive 4 years 3 months
Harsh Sharma and Anil Goswami are mutual person
- Acer Green Carriers Private LimitedActive 10 years 1 month
Harsh Sharma and Anil Goswami are mutual person
- Green Carriers And Contractors Delhi Private LimitedActive 49 years 6 months
Harsh Sharma is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Dec 2020 | ₹9.00 M | Open |
How Many Employees Work at Mbd Pharma?
Unlock and access historical data on people associated with Mbd Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mbd Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mbd Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
